tiprankstipranks
AMARANTUS BIOSCI INC (AMBS)
OTHER OTC:AMBS
US Market
Holding AMBS?
Track your performance easily

Amarantus Biosci (AMBS) Financial Statements

30 Followers

Amarantus Biosci Financial Overview

Amarantus Biosci's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Amarantus Biosci is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 25.20B$ 23.53B$ 23.72B$ 21.91B$ 21.79B
Gross Profit$ 21.78B$ 3.76B$ 3.88B$ 3.22B$ -1.28B
EBIT$ 5.53B$ 4.14B$ 4.02B$ 3.67B$ 1.93B
EBITDA-----
Net Income Common Stockholders$ -385.00M$ 416.00M$ 553.00M$ 1.32B$ 1.08B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 14.40B$ 11.31B$ 12.21B$ 11.82B$ 19.66B
Total Assets$ 441.28B$ 419.15B$ 411.87B$ 401.95B$ 391.00B
Total Debt$ 222.58B$ 204.48B$ 199.64B$ 185.06B$ 175.93B
Net Debt$ 208.18B$ 193.17B$ 187.43B$ 173.24B$ 156.28B
Total Liabilities$ 299.39B$ 285.17B$ 277.85B$ 265.52B$ 256.26B
Stockholders Equity$ 43.75B$ 44.55B$ 45.80B$ 47.54B$ 46.35B
Cash Flow-
Free Cash Flow$ -66.84B$ 981.00M$ 1.60B$ -1.04B$ 2.29B
Operating Cash Flow$ 3.00B$ 5.75B$ 3.13B$ 470.00M$ 2.29B
Investing Cash Flow$ -7.41B$ -32.24B$ -15.55B$ -2.67B$ -12.23B
Financing Cash Flow$ 7.10B$ 25.36B$ 13.10B$ 1.15B$ 11.32B
Currency in USD

Amarantus Biosci Earnings and Revenue History

Amarantus Biosci Debt to Assets

Amarantus Biosci Cash Flow

Amarantus Biosci Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis